Bringing Asacol production in-house through the acquisition of Haupt Pharma Wülfling GmbH
An individual acquisition and manufacturing structure enhancement theme in which Tillotts Pharma AG acquired Haupt Pharma Wülfling GmbH and shifted most Asacol production from outsourcing to in-house manufacturing within the group.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.